Drug · DIN 02446049
MEMANTINE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since June 8, 2018; first marketed October 7, 2015.
- Drug Identification Number (DIN)
- 02446049
- Company (DIN owner)
- Sivem Pharmaceuticals UlcSaint-Laurent, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Memantine N06DX01
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| MEMANTINE HYDROCHLORIDE | 10 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- March 26, 2018: NOC 20665Abbreviated New Drug Submission (ANDS) · Licensing agreeement between two companies
- January 16, 2017: NOC 18874Supplement to an Abbreviated New Drug Submission (SANDS) · Update to product monograph to be in line with crp
- October 5, 2015: NOC 17351Abbreviated New Drug Submission (ANDS) · Licensing agreement between two companies
Other DINs named MEMANTINE
- DIN 02443082 · Marketed
- DIN 02349116 · Cancelled Post Market